ALT5 Sigma Valuation Multiples

Discover ALT5 Sigma's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Bitcoin Group, Amber International, Solana, Antalpha Platform Holding and more.

ALT5 Sigma Overview

About ALT5 Sigma

ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.


Founded

1983

HQ

United States

Employees

10

Financials (FY)

Revenue: -
Net Income: -

EV

$129M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

ALT5 Sigma Stock Performance

ALT5 Sigma has current market cap of $120M, and enterprise value of $129M.

Market Cap Evolution


ALT5 Sigma's stock price is $0.85.

ALT5 Sigma share price decreased by 86.2% in the last year.

See more trading valuation data for ALT5 Sigma
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$129M$120M0.0%---86.2%-

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

ALT5 Sigma Valuation Multiples

ALT5 Sigma Financial Valuation Multiples

As of July 19, 2026, ALT5 Sigma has market cap of $120M and EV of $129M.

LTMLast FY202320242025202620272028

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified ALT5 Sigma Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Valuation Multiples Across 230+ Verticals

ALT5 Sigma Competitors

ALT5 Sigma competitors include Bitcoin Group, Amber International, Solana, Antalpha Platform Holding, Exodus Movement, Prairie Operating Co., DeFi Technologies, Capital B, DMG Blockchain Solutions and WonderFi.

Most ALT5 Sigma public comparables operate across Crypto & Web3 Platforms and FinTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Bitcoin Group10.5x-64.0x-
Amber International1.2x1.3x15.6x17.2x
Solana16.2x9.3x(2.4x)-
Antalpha Platform Holding7.4x8.0x20.9x26.9x
Exodus Movement0.6x0.6x6.2x(27.9x)
Prairie Operating Co.2.3x1.8x3.6x2.9x
DeFi Technologies0.3x0.3x0.4x2.4x
Capital B2.3x2.1x(5.6x)(6.9x)

This data is available for Pro users. Sign up to see all ALT5 Sigma competitors and their valuation data.

Start Free Trial

Acquisitions by ALT5 Sigma

ALT5 Sigma has acquired 5 companies to date.

Last acquisition by ALT5 Sigma was on April 29th 2026. ALT5 Sigma acquired Blockstreet for $43M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by ALT5 Sigma

Blockstreet
Mswipe
ALT5 Sigma
Soin Therapeutics
Description
Blockstreet is a blockchain-based finance platform that issues the USD1 stablecoin and delivers decentralized finance solutions.
Mswipe is a Canadian provider of secure mobile point-of-sale solutions certified for payment processing. Based in Toronto, it equips merchants with hardware and software for contactless transactions including EMV and NFC. The platform integrates with major card networks and supports small businesses across Ontario and Quebec. Established in 2015, Mswipe processes millions in transactions yearly with PCI-compliant security features.
ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.
Soin Therapeutics is a U.S.-based biopharma company advancing treatments for complex regional pain syndrome and orphan neurological disorders. The firm develops low-dose naltrexone formulations and novel peptides targeting neuroinflammation, with Phase II trials underway at 20 U.S. sites. Soin Therapeutics holds FDA orphan drug designations and partners with universities for preclinical models.
HQ CountryUnited StatesUnited StatesUnited StatesUnited States
HQ City
Los Angeles, CA
-
Greenwich, CT
Dayton, OH
Deal Date29 Apr 202613 May 202510 May 202416 Sep 2022
Valuation$43M$6Mundisclosed$13M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all ALT5 Sigma acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About ALT5 Sigma

When was ALT5 Sigma founded?ALT5 Sigma was founded in 1983.
Where is ALT5 Sigma headquartered?ALT5 Sigma is headquartered in United States.
How many employees does ALT5 Sigma have?As of today, ALT5 Sigma has over 10 employees.
Who is the CEO of ALT5 Sigma?ALT5 Sigma's CEO is Tony Isaac.
Is ALT5 Sigma publicly listed?Yes, ALT5 Sigma is a public company listed on Berlin Stock Exchange.
What is the stock symbol of ALT5 Sigma?ALT5 Sigma trades under 5AR1 ticker.
When did ALT5 Sigma go public?ALT5 Sigma went public in 1991.
Who are competitors of ALT5 Sigma?ALT5 Sigma main competitors include Bitcoin Group, Amber International, Solana, Antalpha Platform Holding, Exodus Movement, Prairie Operating Co., DeFi Technologies, Capital B, DMG Blockchain Solutions, WonderFi.
What is the current market cap of ALT5 Sigma?ALT5 Sigma's current market cap is $120M.
Is ALT5 Sigma profitable?No, ALT5 Sigma is not profitable.
How many companies ALT5 Sigma has acquired to date?As of July 2026, ALT5 Sigma has acquired 5 companies.
What was the largest acquisition by ALT5 Sigma?$43M acquisition of Blockstreet on 29th April 2026 was the largest M&A ALT5 Sigma has done to date.
What companies ALT5 Sigma acquired?ALT5 Sigma acquired Blockstreet, Soin Therapeutics, Mswipe, ALT5 Sigma, and GeoTraq.
In how many companies ALT5 Sigma has invested to date?ALT5 Sigma hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to ALT5 Sigma

Lists including ALT5 Sigma

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial